These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24597497)

  • 1. Report of the Subcommittee on Control of Anticoagulation on the determination of the anticoagulant effects of apixaban: communication from the SSC of the ISTH.
    Harenberg J; Du S; Weiss C; Krämer R; Hoppensteadt D; Walenga J;
    J Thromb Haemost; 2014 May; 12(5):801-4. PubMed ID: 24597497
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays. A multicentre French GEHT study.
    Gouin-Thibault I; Flaujac C; Delavenne X; Quenet S; Horellou MH; Laporte S; Siguret V; Lecompte T
    Thromb Haemost; 2014 Feb; 111(2):240-8. PubMed ID: 24172843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay.
    Barrett YC; Wang Z; Frost C; Shenker A
    Thromb Haemost; 2010 Dec; 104(6):1263-71. PubMed ID: 20978714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of direct oral anticoagulants in whole blood and plasma from patients in steady state treatment.
    McGrail R; Revsholm J; Nissen PH; Grove EL; Hvas AM
    Thromb Res; 2016 Dec; 148():107-110. PubMed ID: 27835819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban.
    Harenberg J; Marx S; Weiss C; Krämer R; Samama M; Schulman S;
    J Thromb Haemost; 2012 Jul; 10(7):1433-6. PubMed ID: 22947062
    [No Abstract]   [Full Text] [Related]  

  • 6. Multianalyte Determination of NOACs Using LC-MS/MS and Comparison with Functional Coagulation Assays.
    Slavik L; Lukes J; Friedecky D; Zhanelova M; Nemcova M; Ulehlova J; Prochazkova J; Hlusi A; Palova M; Vaclavik J
    Clin Lab; 2018 Oct; 64(10):1611-1621. PubMed ID: 30336535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for the development of a dedicated pediatric anticoagulation service: communication from the SSC of the ISTH.
    Newall F; Jones S; Bauman M; Bruce A; Massicotte MP; Monagle P;
    J Thromb Haemost; 2015 Jan; 13(1):155-9. PubMed ID: 25331069
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulation without monitoring.
    Chandler WL
    Am J Clin Pathol; 2013 Nov; 140(5):606-7. PubMed ID: 24124137
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of apixaban- and rivaroxaban-associated major bleeding using 4-factor prothrombin complex concentrate.
    Sheikh-Taha M
    Intern Emerg Med; 2019 Mar; 14(2):265-269. PubMed ID: 30414056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of routine coagulation assays to direct oral anticoagulants: patient samples versus commercial drug-specific calibrators.
    Lim MS; Chapman K; Swanepoel P; Enjeti AK
    Pathology; 2016 Dec; 48(7):712-719. PubMed ID: 27780603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme.
    Van Blerk M; Bailleul E; Chatelain B; Demulder A; Devreese K; Douxfils J; Jacquemin M; Jochmans K; Mullier F; Wijns W; China B; Vernelen K; Soumali MR
    Int J Lab Hematol; 2017 Aug; 39(4):402-408. PubMed ID: 28304137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel anticoagulants and laboratory testing.
    Eby C
    Int J Lab Hematol; 2013 Jun; 35(3):262-8. PubMed ID: 23590653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants.
    Reda S; Brügelmann A; Müller J; Oldenburg J; Pötzsch B; Rühl H
    Sci Rep; 2020 Jul; 10(1):12221. PubMed ID: 32699227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laboratory diagnostic with regard to new anticoagulants - monitoring and influence on coagulation tests].
    Nagler M; Wuillemin W
    Ther Umsch; 2012 Nov; 69(11):650-6. PubMed ID: 23117668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single test to assay warfarin, dabigatran, rivaroxaban, apixaban, unfractionated heparin, and enoxaparin in plasma.
    Letertre LR; Gudmundsdottir BR; Francis CW; Gosselin RC; Skeppholm M; Malmstrom RE; Moll S; Hawes E; Francart S; Onundarson PT
    J Thromb Haemost; 2016 May; 14(5):1043-53. PubMed ID: 26924677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How the direct oral anticoagulant apixaban affects hemostatic parameters. Results of a multicenter multiplatform study.
    Tripodi A; Padovan L; Testa S; Legnani C; Chantarangkul V; Scalambrino E; Ludovici S; Bassi L; Peyvandi F
    Clin Chem Lab Med; 2015 Feb; 53(2):265-73. PubMed ID: 25153405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interlaboratory validation of apixaban levels in ex vivo patient samples using a chromogenic anti-factor Xa assay.
    Singh J; Ong DM; Ling V; Lim MS; Malan E; Servadei P; Wallis A; Kelsey G; Chunilal S; Tran H
    Int J Lab Hematol; 2020 Feb; 42(1):e23-e26. PubMed ID: 31286666
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples.
    Bonar R; Favaloro EJ; Mohammed S; Ahuja M; Pasalic L; Sioufi J; Marsden K
    Pathology; 2016 Jan; 48(1):60-71. PubMed ID: 27020211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From heparin to apixaban: anticoagulants cut both ways?].
    Hartung K; Meyer F; Bock F; Isermann B
    Zentralbl Chir; 2014 Feb; 139(1):89-97. PubMed ID: 23460104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH Calibrator.
    Billoir P; Barbay V; Joly LM; Fresel M; Chrétien MH; Le Cam Duchez V
    Ann Pharmacother; 2019 Apr; 53(4):341-347. PubMed ID: 30378443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.